Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Digital biomarkers emerging as important predictive tools to support global COVID-19 pandemic, says GlobalData

Remote patient monitoring (RPM) is accelerating the development and validation of digital biomarkers to help identify patients that are at risk from the coronavirus (COVID-19), supporting the assessment of disease progression and allowing continuous monitoring of disease symptoms, as well as providing data for new outbreaks, says GlobalData, a leading data and analytics company. Roxanne Balfe, […]
Read more

Colorectal cancer screening tests market to surpass $2bn by 2028, says GlobalData

National Colorectal Cancer (CRC) Awareness Month is an opportunity to raise awareness and prevent future cases of CRC. Currently, the global market value for in-vitro diagnostics (IVD) tests for CRC screening is estimated at $771.25m. This is expected to increase even more strongly than test volumes, reaching $2bn by 2028 at a compound annual growth rate (CAGR) of 10%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Colorectal Cancer Screening Tests – In Vitro […]
Read more

Coronavirus pandemic likely to reduce volume of peripheral vascular procedures

The market share for medical devices meant to treat peripheral vascular diseases, including devices such as PTA balloon catheters, stents, atherectomy devices and vascular grafts are expected to suffer due to the coronavirus (COVID-19) pandemic, according to GlobalData, a leading data and analytics company.  The global atherectomy devices market, worth approximately $760m in 2019, may […]
Read more

Sales of N95 respirators in US healthcare institutions doubled between Dec 2019 and Jan 2020, says GlobalData

Heightened demand for N95 respirators means that product counterfeiting, faulty stock, and price gouging are ongoing issues, says GlobalData, a leading data and analytics company. Alison Casey, Medical Device Analyst at GlobalData, comments: “GlobalData estimates that sales of N95 respirators in US healthcare facilities more than doubled between December 2019 and January 2020 to surpass […]
Read more

Rapid diagnostic tests to greatly increase testing capacity for diagnosing COVID-19

There is a current worldwide lack of testing capacity for the novel coronavirus (COVID-19) outbreak. The frontline response for diagnosing COVID-19 has been polymerase chain reaction (PCR) testing. Although PCR is the go-to test for diagnosing an infectious agent, the test protocol is complex and expensive as it is mainly suited to large, centralized diagnostic laboratories, and tests typically take four to six hours to complete, says GlobalData, a leading data and analytics company. The solution to a paucity of testing is rapid point-of-care (POC) tests, […]
Read more

Pipeline in vitro diagnostic products for coronavirus shifts towards point of care and rapid diagnostics

The coronavirus (COVID-19) pandemic has had a dramatic impact on the in vitro diagnostics (IVD) testing market resulting in reagent shortages, new product launches and a host of new pipeline products entering development, says GlobalData, a leading data and analytics company. The current test used to diagnose COVID-19 is an RT-PCR based assay. In recent months, the pandemic has led to overwhelming demands for RT-PCR reagents causing shortages in reagents required for key steps in the testing process, such as RNA extraction kits. Companies […]
Read more
,

With Mylab Covid-19 test kits approval India looks to expand testing criteria, says GlobalData

Following the news that molecular diagnostic company Mylab has received approval for its Covid-19 diagnostic test kits from the Drug Controller General of India (DCGI); Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “India so far has followed a restrictive testing protocol for suspected Covid-19 cases and […]
Read more

India needs to step up production of personal protective equipment to avert supply disruptions amid Covid-19 outbreak, says GlobalData

Anticipating increased demand for personal protective equipment (PPE) products following the rising number of coronavirus (Covid-19) cases, India has recently decided to ban their exports. However, as the entire world is battling the coronavirus outbreak, India needs to speed up domestic production to avert any medical equipment supply chain disruption, says GlobalData, a leading data […]
Read more
1 … 46 47 48 49 50